glp 1 liver toxicity Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty disease (NAFLD) and non-alcoholic steatohepatitis (NASH) GLP-1 and Your Liver: What

In some cases, notably for older drugs that lost their patents years ago but still hold orphan drug exclusivity for a narrow indication, regulatory exclusivity is the only barrier remaining

doi: 10.1053/jhep.2002.36797

3.3 Probiotics promote renal structure and function to prevent lupus nephritis Inflammation of the gut permits harmful germs to enter the bloodstream and secrete LPS, which stimulates the Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) pathway and enhances pro-inflammatory cytokines and autoantibody production, leading to immune complex generation and deposition in the kidney, which causes organ damage